Anika Therapeutics (AKP) Q2 2024 Earnings Report
DE:AKP Q2 2024 EPS Results
- Actual EPS
- EUR 0.15
- Consensus EPS
- EUR 0.06
- Beat/Miss
- Beat by +EUR 0.09
- One Year Ago EPS
- EUR 0.05
DE:AKP Q2 2024 Revenue Results
- Actual Revenue
- EUR 37.48M
- Expected Revenue
- EUR 36.45M
- Beat/Miss
- Beat by +EUR 1.03M
- YoY Revenue Growth
- -5.37%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/08/2024
- Time
- After Close
- Conference Call
- Thursday, August 8, 2024
DE:AKP Upcoming Earnings
Anika Therapeutics's next earnings date is estimated for November 6, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:AKP Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AKP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 06, 2026 | 2026 (Q3) | 0.38- | 0.04 | ― | ― |
| Jul 29, 2026 | 2026 (Q2) | 0.030.38 | -0.12 | 423.08% (+0.49) | |
| Apr 29, 2026 | 2026 (Q1) | 0.000.24 | -0.05 | 550.00% (+0.30) | |
| Feb 26, 2026 | 2025 (Q4) | -0.110.28 | -0.03 | 1133.33% (+0.30) | |
| Nov 05, 2025 | 2025 (Q3) | -0.160.04 | -0.22 | 116.00% (+0.26) | |
| Jul 30, 2025 | 2025 (Q2) | -0.24-0.12 | 0.15 | -176.47% (-0.27) | |
| May 09, 2025 | 2025 (Q1) | -0.08-0.05 | 0.08 | -166.67% (-0.13) | |
| Mar 12, 2025 | 2024 (Q4) | -0.20-0.03 | 0.04 | -160.00% (-0.07) | |
| Oct 31, 2024 | 2024 (Q3) | 0.08-0.22 | 0 | ― | |
| Aug 08, 2024 | 2024 (Q2) | 0.060.15 | 0.05 | 183.33% (+0.10) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
